1. FDA's draft guidance on laboratory‐developed tests increases clinical and economic risk to adoption of pharmacogenetic testing. (July 2015) Authors: Levy, Kenneth D.; Pratt, Victoria M.; Skaar, Todd C.; Vance, Gail H.; Flockhart, David A. Journal: Journal of clinical pharmacology Issue: Volume 55:Number 7(2015:Jul.) Page Start: 725 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. IGNITE network: Response of patients to genomic medicine interventions. Issue 5 (20th March 2019) Authors: Orlando, Lori A.; Voils, Corrine; Horowitz, Carol R.; Myers, Rachel A.; Arwood, Meghan J.; Cicali, Emily J.; McDonough, Caitrin W.; Pollin, Toni I.; Guan, Yue; Levy, Kenneth D.; Ramirez, Andrea; Quittner, Alexandra; Madden, Ebony B. Journal: Molecular genetics & genomic medicine Issue: Volume 7:Issue 5(2019) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗